Nivolumab (Ingredient)
Drugbank ID: DB09035
ATC code: L01XC17
The information below refers to products available in the United States that contain nivolumab.
Products containing nivolumab
nivolumab systemic
Brand name: Opdivo
Drug class: Immune checkpoint inhibitors (PD-1 and PD-L1 inhibitors)
Nivolumab systemic is used in the treatment of:
- Bladder Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Gastroesophageal Cancer
- Gastroesophageal Junction Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Hodgkin's Lymphoma
- Malignant Pleural Mesothelioma
- Melanoma
- Melanoma, Metastatic
- Non Small Cell Lung Cancer
- Renal Cell Carcinoma (RCC)
- Stomach Cancer
- Urothelial Carcinoma
Multi-ingredient medications containing nivolumab
hyaluronidase/nivolumab systemic
Brand name: Opdivo Qvantig
Drug class: Immune checkpoint inhibitors (PD-1 and PD-L1 inhibitors)
Hyaluronidase/nivolumab systemic is used in the treatment of:
- Bladder Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Gastroesophageal Cancer
- Gastroesophageal Junction Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Melanoma
- Non Small Cell Lung Cancer
- Renal Cell Carcinoma (RCC)
- Urothelial Carcinoma
nivolumab/relatlimab systemic
Brand name: Opdualag
Drug class: antineoplastic combinations
Nivolumab/relatlimab systemic is used in the treatment of:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.